R F INDUSTRIES LTD
For the period ended Jul 31, 2025. Filed Sep 11, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jul 31, 2025 · Filed Sep 11, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. Financial Statements
CONDENSED CONSOLIDATED BALANCE SHEETS
| July 31, | October 31, | |
|---|---|---|
| 2025 | 2024 | |
| (Unaudited) | (Note 1) | |
| ASSETS | ||
| CURRENT ASSETS | ||
| Cash and cash equivalents | $3,000 | $839 |
| Trade accounts receivable, net of allowance for credit losses of $126 and $159, respectively | 15,348 | 12,119 |
| Inventories | 14,169 | 14,725 |
| Other current assets | 1,569 | 1,430 |
| TOTAL CURRENT ASSETS | 34,086 | 29,113 |
| Property and equipment: | ||
| Equipment and tooling | 4,957 | 4,825 |
| Furniture and office equipment | 6,326 | 6,300 |
| 11,283 | 11,125 | |
| Less accumulated depreciation | 6,915 | 6,312 |
| Total property and equipment, net | 4,368 | 4,813 |
| Operating lease right-of-use assets, net | 14,255 | 15,265 |
| Goodwill | 8,085 | 8,085 |
| Amortizable intangible assets, net | 10,675 | 11,908 |
| Non-amortizable intangible assets | 1,174 | 1,174 |
| Other assets | 558 | 688 |
| TOTAL ASSETS | $73,201 | $71,046 |
CONDENSED CONSOLIDATED BALANCE SHEETS
| July 31, | October 31, | |
|---|---|---|
| 2025 | 2024 | |
| (Unaudited) | (Note 1) | |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| CURRENT LIABILITIES | ||
| Accounts payable | $4,806 | $3,798 |
| Accrued expenses | 6,334 | 4,247 |
| Line of credit | 7,828 | 8,197 |
| Current portion of operating lease liabilities | 2,045 | 1,848 |
| TOTAL CURRENT LIABILITIES | 21,013 | 18,090 |
| Operating lease liabilities | 17,209 | 18,680 |
| Deferred tax liabilities | 207 | 210 |
| TOTAL LIABILITIES | 38,429 | 36,980 |
| COMMITMENTS AND CONTINGENCIES | ||
| STOCKHOLDERS’ EQUITY | ||
| Common stock - authorized 20,000,000 shares of $0.01 par value; 10,667,447 and 10,544,431 shares issued and outstanding at July 31, 2025 and October 31, 2024, respectively | 107 | 106 |
| Additional paid-in capital | 27,791 | 26,988 |
| Retained earnings | 6,874 | 6,972 |
| TOTAL STOCKHOLDERS' EQUITY | 34,772 | 34,066 |
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $73,201 | $71,046 |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
| Three Months Ended July 31, | Nine Months Ended July 31, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Net sales | $19,790 | $16,836 | $57,900 | $46,404 |
| Cost of sales | 13,071 | 11,875 | 39,514 | 33,316 |
| Gross profit | 6,719 | 4,961 | 18,386 | 13,088 |
| Operating expenses: | ||||
| Engineering | 759 | 653 | 2,124 | 2,059 |
| Selling and general | 5,240 | 4,727 | 15,380 | 13,948 |
| Total operating expenses | 5,999 | 5,380 | 17,504 | 16,007 |
| Operating income (loss) | 720 | (419) | 882 | (2,919) |
| Other expense | (240) | (338) | (721) | (676) |
| Income (loss) before provision (benefit) for income taxes | 480 | (757) | 161 | (3,595) |
| Provision (benefit) for income taxes | 88 | (52) | 259 | 2,766 |
| Consolidated net income (loss) | $392 | $(705) | $(98) | $(6,361) |
| Earnings (loss) per share: | ||||
| Basic | $0.04 | $(0.07) | $(0.01) | $(0.61) |
| Diluted | $0.04 | $(0.07) | $(0.01) | $(0.61) |
| Weighted average shares outstanding: | ||||
| Basic | 10,668,375 | 10,495,082 | 10,632,566 | 10,466,862 |
| Diluted | 10,774,304 | 10,495,082 | 10,632,566 | 10,466,862 |
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’** EQUITY**
(In thousands, except share amounts)
| Additional | |||||
|---|---|---|---|---|---|
| Common Stock · Paid-in · Retained | |||||
| Shares | Amount | Capital | Earnings | Total | |
| Balance, May 1, 2025 | 10,668,653 | $107 | $27,581 | $6,482 | $34,170 |
| Stock-based compensation expense | - | - | 219 | - | 219 |
| Tax withholding related to vesting of restricted stock | (1,206) | - | (9) | - | (9) |
| Consolidated net income | - | - | - | 392 | 392 |
| Balance, July 31, 2025 | 10,667,447 | $107 | $27,791 | $6,874 | $34,772 |
| Additional | |||||
|---|---|---|---|---|---|
| Common Stock · Paid-in · Retained | |||||
| Shares | Amount | Capital | Earnings | Total | |
| Balance, November 1, 2024 | 10,544,431 | $106 | $26,988 | $6,972 | $34,066 |
| Exercise of stock options | 50,623 | 1 | 206 | - | 207 |
| Stock-based compensation expense | - | - | 640 | - | 640 |
| Issuance of restricted stock | 82,500 | - | - | - | - |
| Tax withholding related to vesting of restricted stock | (10,107) | - | (43) | - | (43) |
| Consolidated net loss | - | - | - | (98) | (98) |
| Balance, July 31, 2025 | 10,667,447 | $107 | $27,791 | $6,874 | $34,772 |
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’** EQUITY**
(In thousands, except share amounts)
| Additional | |||||
|---|---|---|---|---|---|
| Common Stock · Paid-in · Retained | |||||
| Shares | Amount | Capital | Earnings | Total | |
| Balance, May 1, 2024 | 10,495,548 | $105 | $26,589 | $7,915 | $34,609 |
| Stock-based compensation expense | - | - | 241 | - | 241 |
| Tax withholding related to vesting of restricted stock | (2,063) | - | (9) | - | (9) |
| Consolidated net loss | - | - | - | (705) | (705) |
| Balance, July 31, 2024 | 10,493,485 | $105 | $26,821 | $7,210 | $34,136 |
| Additional | |||||
|---|---|---|---|---|---|
| Common Stock · Paid-in · Retained | |||||
| Shares | Amount | Capital | Earnings | Total | |
| Balance, November 1, 2023 | 10,343,223 | $104 | $26,087 | $13,571 | $39,762 |
| Stock-based compensation expense | - | - | 744 | - | 744 |
| Issuance of restricted stock | 152,325 | 1 | (1) | - | - |
| Tax withholding related to vesting of restricted stock | (2,063) | - | (9) | - | (9) |
| Consolidated net loss | - | - | - | (6,361) | (6,361) |
| Balance, July 31, 2024 | 10,493,485 | $105 | $26,821 | $7,210 | $34,136 |
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
| Nine Months Ended July 31, | ||
|---|---|---|
| 2025 | 2024 | |
| OPERATING ACTIVITIES: | ||
| Consolidated net loss | $(98) | $(6,361) |
| Adjustments to reconcile consolidated net loss to net cash provided by operating activities: | ||
| Bad debt expense | 31 | 2 |
| Depreciation and amortization | 1,848 | 1,904 |
| Gain on disposal of fixed assets | (12) | - |
| Stock-based compensation expense | 640 | 744 |
| Amortization of debt issuance cost | 130 | 68 |
| Tax payments related to shares cancelled for vested restricted stock awards | (43) | (9) |
| Deferred income taxes | (3) | 2,674 |
| Extinguishment of debt issuance cost | - | 14 |
| Changes in operating assets and liabilities: | ||
| Trade accounts receivable | (3,260) | (401) |
| Inventories | 556 | 3,681 |
| Other current assets | (139) | 240 |
| Right-of-use assets | (264) | 431 |
| Other long-term assets | - | (1) |
| Accounts payable | 1,008 | (52) |
| Accrued expenses | 2,087 | 475 |
| Net cash provided by operating activities | 2,481 | 3,409 |
| INVESTING ACTIVITIES: | ||
| Proceeds from sale of fixed assets | 12 | - |
| Capital expenditures | (170) | (564) |
| Net cash used in investing activities | (158) | (564) |
| FINANCING ACTIVITIES: | ||
| Line of credit proceeds (payments) | (369) | 7,704 |
| Debt issuance cost | - | (520) |
| Proceeds from exercise of stock options | 207 | - |
| Term Loan payments | - | (13,162) |
| Net cash used in financing activities | (162) | (5,978) |
| Net increase (decrease) in cash and cash equivalents | 2,161 | (3,133) |
| Cash and cash equivalents, beginning of period | 839 | 4,897 |
| Cash and cash equivalents, end of period | $3,000 | $1,764 |
| Supplemental cash flow information – income taxes paid | $169 | $64 |
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Note 1–** Unaudited interim condensed consolidated financial statements**
Our accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments, which are normal and recurring, and other items of gain (loss) and expense required in our view under ASC 270,Interim Reporting, have been included for a fair statement of the financial position. Information included in the condensed consolidated balance sheet as of October 31, 2024 has been derived from, and certain terms used herein are defined in, the audited consolidated financial statements of RF Industries, Ltd. as of October 31, 2024 included in our Annual Report on Form 10-K (the “Form 10-K”) for the year ended October 31, 2024 that was previously filed with the Securities and Exchange Commission (“SEC”). Operating results for the nine months ended July 31, 2025 are not necessarily indicative of the results that may be expected for the year ended October 31, 2025. The unaudited condensed consolidated financial statements should be read in conjunction with the condensed consolidated financial statements and footnotes thereto included in our Form 10-K.
Our accompanying unaudited condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates continuity of operations, realization of assets, and satisfaction of liabilities in the ordinary course of business. The propriety of using the going-concern basis is dependent upon, among other things, the achievement of future profitable operations, the ability to generate sufficient cash from operations and potential other funding sources, in addition to cash on-hand along with the current credit facility with Eclipse Business Capital (“EBC”) to meet its obligations as they become due.
For the three and nine months ended July 31, 2025, we generated operating income of $719,000 and $882,000, respectively, compared to an operating loss of $419,000 and $2,919,000 for the same periods last year. This is a result of an increase in sales, as well as certain cost-cutting measures we implemented to reduce our operating expenses and to help drive positive operating cash flow and increase liquidity. Efforts to reduce expenses included consolidating facilities and recognizing the related operating efficiencies and synergies in our production operations. The Company intends to continue to pursue additional continuous improvement and cost reduction measures, as well as organic growth in revenue and profitability.
On March 15, 2024, the Company entered into the loan and security agreement with EBC, as administrative agent, pursuant to which proceeds from initial drawings under the credit facility with EBC were used to repay in full the outstanding obligations under the prior revolving credit facility and term loan that we had with Bank of America, N.A. (the “Term Loan”). The Term loan was terminated upon entry into the loan and security agreement with EBC.
Principles of consolidation
The accompanying unaudited condensed consolidated financial statements include the accounts of RF Industries, Ltd., Cables Unlimited, Inc. (“Cables Unlimited”), Rel-Tech Electronics, Inc. (“Rel-Tech”), C Enterprises, Inc. (“C Enterprises”), Schroff Technologies International, Ltd. (“Schrofftech”), and Microlab/FXR LLC (“Microlab”), wholly-owned subsidiaries of RF Industries, Ltd. All intercompany balances and transactions have been eliminated in consolidation.
Fair value measurement
We measure at fair value certain financial assets and liabilities. Fair value is defined as the price that would be received to sell an asset or transfer a liability in an orderly transaction between market participants at the measurement date. GAAP specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our market assumptions. These two types of inputs have created the following fair-value hierarchy:
Level 1— Quoted prices for identical instruments in active markets;
Level 2— Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and
Level 3— Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
As of July 31, 2025 and October 31, 2024, the carrying amounts reflected in the accompanying condensed consolidated balance sheets for cash and cash equivalents, accounts receivable, and accounts payable approximate their carrying value due to their short-term nature.
Recent accounting standards
Recently issued accounting pronouncements not yet adopted:
In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07,Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which expands annual and interim disclosure requirements for reportable segments, primarily through enhanced disclosures about significant segment expenses. ASU 2023-07 is effective for our annual periods beginning January 1, 2024, and for interim periods beginning January 1, 2025, with early adoption permitted. We are currently evaluating the potential effect that the updated standard will have on our financial statement disclosures for the year ending October 31, 2025.
In December 2023, the FASB issued ASU 2023-09,Income Taxes (Topic 740): Improvements to Income Tax Disclosures, to expand the disclosure requirements for income taxes, specifically related to the effective tax rate reconciliation and income taxes paid. ASU 2023-09 is effective for our annual periods beginning January 1, 2025, with early adoption permitted. We are currently evaluating the potential effect that the updated standard will have on our financial statement disclosures.
Note 2–** Concentrations of credit risk**
Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. We maintain our cash and cash equivalents with high-credit quality financial institutions. At July 31, 2025, we had cash and cash equivalent balances in excess of federally insured limits in the amount of approximately $2.7 million.
Sales from each customer that were 10% or greater of net sales were as follows:
| Three Months Ended July 31, | Nine Months Ended July 31, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Wireless provider A | 11% | 11% | - | - |
| Distributor A | 15% | - | - | - |
| Distributor B | - | 13% | - | - |
For the three months ended July 31, 2025, one wireless provider accounted for 11% of net sales and 17% of total net accounts receivable balance, andone distributor customer accounted for 15% of net sales and 22% of total net accounts receivable balance. For the nine months ended July 31, 2025, no customers accounted for 10% or more of net sales, and the same wireless provider and distributor accounted for 17% and 22% of total net accounts receivable balance, respectively. For the three months ended July 31, 2024, the same wireless provider accounted for 11% of net sales and 18% of total net accounts receivable balance, and a different distributor customer accounted for 13% of net sales and 10% of total net accounts receivable balance. For the nine months ended July 31, 2024, no customers accounted for 10% or more of net sales, and the wireless provider andone distributor customer accounted for 18% and 10% of total net accounts receivable balance, respectively. Although these customers have been significant customers of the Company, the written agreements with these customers do not have any minimum purchase obligations and these customers could stop buying our products at any time and for any reason. A reduction, delay or cancellation of orders from these customers or the loss of these customers could significantly reduce our future revenues and profits.
Note 3–** Inventories and major vendors**
Inventories, consisting of materials, labor and manufacturing overhead, are stated at the lower of cost or net realizable value. Cost has been determined using the weighted average cost method. Inventories consist of the following (in thousands):
| July 31, 2025 | October 31, 2024 | |
|---|---|---|
| Raw materials and supplies | $9,586 | $10,886 |
| Work in process | 793 | 530 |
| Finished goods | 3,790 | 3,309 |
| Totals | $14,169 | $14,725 |
For the three months ended July 31, 2025 and 2024, no single vendor accounted for 10% or more of inventory purchases. For the nine months ended July 31, 2025 and 2024, no single vendor accounted for 10% or more of inventory purchases. We have arrangements with these vendors to purchase products based on purchase orders that we periodically issue.
Note 4–** Other current assets**
Other current assets consist of the following (in thousands):
| July 31, 2025 | October 31, 2024 | |
|---|---|---|
| Prepaid taxes | $139 | $262 |
| Prepaid expense | 1,001 | 699 |
| Deposits | 378 | 329 |
| Other | 51 | 140 |
| Totals | $1,569 | $1,430 |
Note 5–** Accrued expenses and other current liabilities**
Accrued expenses consist of the following (in thousands):
| July 31, 2025 | October 31, 2024 | |
|---|---|---|
| Wages payable | $2,993 | $2,357 |
| Accrued receipts | 1,602 | 762 |
| Deferred revenue | 521 | - |
| Other accrued expenses | 1,218 | 1,128 |
| Totals | $6,334 | $4,247 |
Accrued receipts represent purchased inventory for which invoices have not been received.
Note 6–** Income (Loss) per share**
Basic income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing net income by the weighted average number of common shares outstanding increased by the effects of assuming that other potentially dilutive securities (such as stock options) outstanding during the period had been exercised and the treasury stock method had been applied. During the three months ended July 31, 2025, we reported a net income. In periods with a net loss, the basic loss per share equals the diluted loss per share as all common stock equivalents are excluded from the per share calculation due to their anti-dilutive effect. Potentially issuable securities that are out-of-the-money totaled 50,000 and 846,889 shares for the three months ended July 31, 2025 and 2024, respectively, and 50,000 and 846,889 shares for the nine months ended July 31, 2025 and 2024, respectively, and were excluded from the calculation of diluted per share amounts because of their anti-dilutive effect.
The following table summarizes the computation of basic and diluted weighted average shares outstanding:
| Three Months Ended July 31, | Nine Months Ended July 31, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Weighted average shares outstanding for basic earnings per share | 10,668,375 | 10,495,082 | 10,632,566 | 10,466,862 |
| Add effects of potentially dilutive securities-assumed exercise of stock options | 105,929 | - | - | - |
| Weighted average shares outstanding for diluted earnings per share | 10,774,304 | 10,495,082 | 10,632,566 | 10,466,862 |
Note 7–** Stock-based compensation and equity transactions**
On November 1, 2023, we granted 15,202 shares of restricted stock to one officer in lieu of cash compensation. The shares of restricted stock vest overone year as follows: (i)one-quarter of the restricted shares on January 31, 2024 and (ii) the remaining restricted shares shall vest inthree equal quarterly installments.
On January 11, 2024, we granted a total of 110,099 shares of restricted stock and 220,001 incentive stock options to one manager and three officers, respectively. The shares of restricted stock and incentive stock options vest over four years as follows: (i)one-quarter of the restricted shares and options shall vest on January 11, 2025 and (ii) the remaining restricted shares and options shall vest in 12 equal quarterly installments over the next three years.
On April 16, 2024, we granted a total of 25,000 incentive stock options to three managers. The shares of incentive stock options vest over four years as follows: (i)one-quarter of the restricted shares and options shall vest on April 16, 2025 and (ii) the remaining restricted shares and options shall vest in 12 equal quarterly installments over the next three years.
On December 2, 2024, we granted 47,500 incentive stock options to seven managers. The shares of incentive stock options vest equally over four years as follows: (i)one-quarter of the options shall vest on December 2, 2025 and (ii) the remaining options shall vest in three equal annual installments over the next three years.
On January 13, 2025, we granted a total of 82,500 shares of restricted stock and 165,000 incentive stock options to two managers and three officers. The shares of restricted stock and incentive stock options vest over four years as follows: (i)one-quarter of the restricted shares and options shall vest on January 13, 2026 and (ii) the remaining restricted shares and options shall vest in 12 equal quarterly installments over the next three years.
No other shares or options were granted to Company employees during the three and nine months ended July 31, 2025 and 2024.
The fair value of each option granted during the nine months ended July 31, 2025 and 2024 was estimated on the grant date using the Black-Scholes option pricing model with the following assumptions:
| Nine Months Ended July 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Weighted average volatility | 44.37% | 51.30% |
| Expected dividends | 0.00% | 0.00% |
| Expected term (in years) | 6.14 | 7.00 |
| Risk-free interest rate | 4.54% | 4.00% |
| Weighted average fair value of options granted during the year | $1.85 | $3.97 |
| Weighted average fair value of options vested during the year | $2.38 | $5.08 |
Expected volatilities are based on historical volatility of our stock price and other factors. We used the historical method to calculate the expected life of the 2025 and 2024 option grants. The expected life represents the period of time that options granted are expected to be outstanding. The risk-free rate is based on the U.S. Treasury rate with a maturity date corresponding to the options’ expected life. The dividend yield is based upon the historical dividend yield.
Company stock option plans
Descriptions of our stock option plans are included in Note 8 to our audited financial statements included in our Annual Report on Form 10-K for the year ended October 31, 2024. A summary of the status of the options granted under our stock option plans as of July 31, 2025 and the changes in options outstanding during the nine months then ended is presented in the table that follows:
| Shares or · Weighted | ||||
|---|---|---|---|---|
| Price Per · Average | ||||
| Share · Exercise Price | ||||
| Outstanding at beginning of November 1, 2024 | 874,816 | $5.10 | ||
| Options granted | 212,500 | $3.97 | ||
| Options exercised | (50,623) | $4.07 | ||
| Options canceled or expired | (25,000) | $8.69 | ||
| Options outstanding at July 31, 2025 | 1,011,693 | $4.82 | ||
| Options exercisable at July 31, 2025 | 562,868 | $5.52 | ||
| Options vested and expected to vest at July 31, 2025 | 1,011,693 | $4.82 | ||
| Option price range at July 31, 2025 | $1.90 | - | $8.69 | |
| Aggregate intrinsic value of options exercised during year | $43,756 | |||
Weighted average remaining contractual life of options outstanding as of July 31, 2025:6.91 years
Weighted average remaining contractual life of options exercisable as of July 31, 2025:5.67 years
Weighted average remaining contractual life of options vested and expected to vest as of July 31, 2025:6.91 years
Aggregate intrinsic value of options outstanding at July 31, 2025: $3,480,000
Aggregate intrinsic value of options exercisable at July 31, 2025: $1,551,000
Aggregate intrinsic value of options vested and expected to vest at July 31, 2025: $3,480,000
As of July 31, 2025, $919,000 and $686,000 of expenses with respect to nonvested stock options and restricted shares, respectively, have yet to be recognized but are expected to be recognized over a weighted average period of 1.4 and 1.3 years, respectively.
Stock option expense
During the three months ended July 31, 2025 and 2024, stock-based compensation expense totaled $219,000 and $241,000, respectively, and was classified in selling and general expense. During the nine months ended July 31, 2025 and 2024, stock-based compensation expense totaled $640,000 and $744,000, respectively, and was classified in selling and general expense.
Note 8–** Segment information**
We aggregate operating divisions intotwo reporting segments that have similar economic characteristics primarily in the following areas: (1) the nature of the product and services; (2) the nature of the production process; (3) the type or class of customer for their products and services; (4) the methods used to distribute their products or services; and (5) if applicable, the nature of the regulatory environment. Based upon this evaluation, as of July 31, 2025, we hadtwo reportable segments – RF Connector and Cable Assembly (“RF Connector”) segment and Custom Cabling Manufacturing and Assembly (“Custom Cabling”) segment.
The RF Connector segment consists of three divisions and the Custom Cabling segment also consists of three divisions. The six divisions that met the quantitative thresholds for segment reporting are the RF Connector and Cable Assembly division (“RF Connector division”), Cables Unlimited, Rel-Tech, C Enterprises, Schrofftech, and Microlab. While each segment has similar products and services, there was little overlapping of these services to their customer base. The biggest difference in segments is in the channels of sales; sales or products and services for the RF Connector segment were primarily through the distribution channel, while the Custom Cabling segment sales were through a combination of distribution and direct to end customer.
As reviewed by our chief operating decision maker, we evaluate the performance of each segment based on income or loss before income taxes. We charge depreciation and amortization directly to each division within the segment. Accounts receivable, inventory, property and equipment, right-of-use assets, goodwill and intangible assets are the only assets identified by segment. Except as discussed above, the accounting policies for segment reporting are the same for the Company as a whole.
All of our operations are conducted in the United States; however, we derive a portion of our revenue from export sales. We attribute sales to geographic areas based on the location of the customers. The following table presents the sales by geographic area for the three and nine months ended July 31, 2025 and 2024 (in thousands):
| Three Months Ended July 31, | Nine Months Ended July 31, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| United States | $18,432 | $15,473 | $52,952 | $41,948 |
| Foreign Countries: | ||||
| Canada | 1,052 | 765 | 3,678 | 2,595 |
| Germany | 138 | 23 | 305 | 118 |
| All Other | 168 | 575 | 965 | 1,743 |
| 1,358 | 1,363 | 4,948 | 4,456 | |
| Totals | $19,790 | $16,836 | $57,900 | $46,404 |
Net sales, (loss) income before provision for income taxes and other related segment information for the three months ended July 31, 2025 and 2024 are as follows (in thousands):
| RF Connector · Custom Cabling | |||||
|---|---|---|---|---|---|
| and · Manufacturing and | |||||
| 2025 · Cable Assembly · Assembly · Corporate · Total | |||||
| Net sales | $9,230 | $10,560 | $ | - | $19,790 |
| (Loss) income before provision for income taxes | (1,424) | 2,144 | (240) | 480 | |
| Depreciation and amortization | 518 | 99 | - | 617 | |
| Total assets | 45,675 | 22,398 | 5,128 | 73,201 | |
| Expenditures for Segment Assets | 60 | 48 | - | 108 | |
| Net sales | $9,697 | $7,139 | $ | - | $16,836 |
| (Loss) income before provision for income taxes | (715) | 297 | (339) | (757) | |
| Depreciation and amortization | 525 | 113 | - | 638 | |
| Total assets | 49,355 | 18,112 | 4,393 | 71,860 | |
| Expenditures for Segment Assets | 249 | 3 | - | 252 | |
Net sales, (loss) income before provision for income taxes and other related segment information for the nine months ended July 31, 2025 and 2024 are as follows (in thousands):
| RF Connector · Custom Cabling | |||||
|---|---|---|---|---|---|
| and · Manufacturing and | |||||
| 2025 · Cable Assembly · Assembly · Corporate · Total | |||||
| Net sales | $27,311 | $30,589 | $ | - | $57,900 |
| (Loss) income before provision for income taxes | (4,209) | 5,265 | (894) | 161 | |
| Depreciation and amortization | 1,554 | 294 | - | 1,848 | |
| Total assets | 45,675 | 22,398 | 5,128 | 73,201 | |
| Expenditures for Segment Assets | 83 | 86 | - | 169 | |
| Net sales | $28,406 | $17,998 | $ | - | $46,404 |
| (Loss) income before provision for income taxes | (3,104) | 386 | (877) | (3,595) | |
| Depreciation and amortization | 1,610 | 294 | - | 1,904 | |
| Total assets | 49,355 | 18,112 | 4,393 | 71,860 | |
| Expenditures for Segment Assets | 544 | 20 | - | 564 | |
Note 9–** Income taxes**
In accordance with applicable accounting guidance, the Company is required to use an estimated annual effective tax rate to compute its tax provision during an interim period. However, there is an exception to the use of this method when a reliable estimate of the annual effective tax rate cannot be made due to the sensitivity of changes in estimates of ordinary income (loss). In that case, an entity may report the actual tax provision or benefit applicable when annual income (loss) cannot be estimated as a discrete item in the interim period. This exception was used in determining the tax provision for the nine months ended July 31, 2025.
We recorded income tax provisions (benefits) of $88,000 and ($52,000) for the three months ended July 31, 2025 and 2024, respectively. The effective tax rate for the three months ended July 31, 2025 and 2024 was 18.3% and 6.9%, respectively. For the nine months ended July 31, 2025 and 2024, we recorded income tax provisions of $259,000 and $2,766,000, respectively. The effective tax rate for the nine months ended July 31, 2025 and 2024 was 160.9% and (76.9%), respectively. The effective tax rate for the three months and nine months ended July 31, 2025 differed from the U.S. statutory tax rate of 21% primarily due to state taxes, various permanent differences, research and development tax credits, unrecognized tax benefits and change in valuation allowance.
We had $241,000 and $186,000 of unrecognized tax benefits, as of July 31, 2025 and October 31, 2024, respectively. The unrecognized tax benefits, if recognized, would result in a net tax benefit of $195,000 as of July 31, 2025.
The Company assesses all positive and negative evidence in determining if, based on the weight of such evidence, a valuation allowance is required to be recorded against the deferred tax assets as of July 31, 2025. The Company has evaluated future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. In making such judgements, significant weight is given to evidence that can be objectively verified. After analyzing all available evidence, including the recent trend of losses, the Company has determined that it is not more likely than not that all of its deferred tax assets will be realized, and therefore, has a partial valuation allowance against its deferred tax assets. The Company's valuation allowance was $4,146,000 and $3,962,000 as of July 31, 2025 and October 31, 2024.
On July 4, 2025, President Donald Trump signed into law the reconciliation tax bill, commonly referred to as the “One Big Beautiful Bill Act” (OBBBA), which constitutes the enactment date under GAAP. Key corporate tax provisions of the OBBBA include the restoration of 100% bonus depreciation, the introduction of new Section 174A permitting immediate expensing of domestic research and experimental (R&E) expenditures, modifications to Section 163(j) interest expense limitations, updates to the rules governing foreign-derived intangible income (FDII), and the expansion of Section 162(m) aggregation requirements.
Under GAAP, the effects of changes in tax laws are recognized in the period in which the new law is enacted. Accordingly, the impact of the OBBBA is reflected in the Company’s financial statements for the third quarter of fiscal 2025, to the extent applicable, as the tax law changes primarily take effect for the fiscal year ending October 31, 2026. The tax law changes did not change the annual effective tax rate for fiscal 2025 or the valuation allowance assessment. The Company is currently evaluating the impact of the OBBBA for fiscal 2026, and an estimate of the financial effect is not available yet.
Note 10–** Intangible assets**
Intangible assets consist of the following as of July 31, 2025 and October 31, 2024 (in thousands):
| July 31, 2025 | October 31, 2024 | |
|---|---|---|
| Amortizable intangible assets: | ||
| Non-compete agreement (estimated life five years) | $423 | $423 |
| Accumulated amortization | (423) | (423) |
| - | - | |
| Customer relationships (estimated lives 7 - 15 years) | 6,058 | 6,058 |
| Accumulated amortization | (4,138) | (3,848) |
| 1,920 | 2,210 | |
| Backlog (estimated life one - two years) | 327 | 327 |
| Accumulated amortization | (327) | (327) |
| - | - | |
| Patents (estimated life 10 - 14 years) | 368 | 368 |
| Accumulated amortization | (233) | (208) |
| 135 | 160 | |
| Tradename (estimated life 15 years) | 1,700 | 1,700 |
| Accumulated amortization | (387) | (302) |
| 1,313 | 1,398 | |
| Proprietary technology (estimated life 10 years) | 11,100 | 11,100 |
| Accumulated amortization | (3,793) | (2,960) |
| 7,307 | 8,140 | |
| Totals | $10,675 | $11,908 |
| Non-amortizable intangible assets: | ||
| Trademarks | $1,174 | $1,174 |
Amortization expense for the nine months ended July 31, 2025 and the year ended October 31, 2024 was $1,233,000 and $1,688,000, respectively. As of July 31, 2025, the weighted-average amortization period for the amortizable intangible assets is 6.91 years.
Note 11–** Commitments**
We have operating leases for corporate offices, manufacturing facilities, and certain storage units. Our leases have remaining lease terms ofone year to 10 years. A portion of our operating leases are leased from K&K Unlimited, a company controlled by Darren Clark, the former owner and current President of Cables Unlimited, to whom we make rent payments totaling $18,000 per month.
We also have other operating leases for certain equipment. The components of our facilities and equipment operating lease expenses for the periods ended July 31, 2025 and 2024 were as follows (in thousands):
| Three Months Ended July 31, | Nine Months Ended July 31, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Operating lease cost | $733 | $749 | $2,212 | $2,217 |
As of July 31, 2025, operating lease right-of-use assets were $14.3 million and operating lease liabilities totaled $19.3 million, of which $2.0 million is classified as current. There wereno finance leases as of July 31, 2025. Future minimum lease payments under non-cancellable leases as of July 31, 2025 are a total of $25.2 million.
Note 12–** Term Loan and Line of credit**
On March 15, 2024, we entered into a loan and security agreement (the “EBC Credit Agreement”) with EBC, as administrative agent, and used proceeds from the initial drawings under the EBC Credit Facilities (as defined below) to repay in full outstanding obligations under the loan agreement we had entered into in February 2022 with Bank of America, N.A. (the “BofA Loan Agreement”) and to pay fees, premiums, costs and expenses, including fees payable in connection with the EBC Credit Agreement. The BofA Loan Agreement was terminated upon entry into the EBC Credit Agreement and is no longer in effect.
The EBC Credit Agreement provides for (i) a senior secured revolving loan facility of up to $15.0 million (the “EBC Revolving Loan Facility”) and (ii) a senior secured revolving credit facility of up to $1.0 million (the “EBC Additional Line” and, together with the EBC Revolving Loan Facility, the “EBC Credit Facilities”) (with a $3.0 million swingline loan sublimit). On June 14, 2024, the parties entered into a First Amendment to the EBC Credit Agreement (the “First Amendment”) providing for a modified EBC Additional Line of $1.0 million through July 12, 2024, $666,667 from July 13, 2024 through August 11, 2024 and $333,333 from August 12, 2024 through September 10, 2024. Availability of borrowings under the EBC Credit Facilities will be based upon a borrowing base formula and periodic borrowing base certifications valuing certain of our accounts receivable and inventories, as reduced by certain reserves, if any.
In the absence of an Event of Default (as defined in the EBC Credit Agreement) or certain other events (including the inability of EBC to determine the secured overnight financing rate “SOFR”), borrowings under (a) the EBC Revolving Loan Facility accrue interest at a rate of the one-month term SOFR reference rate plus an adjustment of 0.11448% (“Adjusted Term SOFR”) plus 5.00%, and (b) the EBC Additional Line accrue interest at a rate of Adjusted Term SOFR plus 6.50%, in each case subject to a floor of 2.00% for Adjusted Term SOFR. We will be required to pay a commitment fee of 0.50% per annum for the unused portion of the EBC Revolving Loan Facility. In addition to the foregoing unused commitment fee, we are required to pay certain other administrative fees pursuant to the terms of the EBC Credit Agreement.
Borrowings under the EBC Credit Agreement are secured by a security interest in certain assets of the Company and are subject to certain loan covenants. The EBC Credit Facilities require the maintenance of certain financial covenants, including (i) Excess Availability (as defined in the EBC Credit Agreement) of at least, as of any date of determination, an amount equal to the greater of (a) $1.0 million and (b)10% of the Adjusted Borrowing Base (as defined in the EBC Credit Agreement), unless as of the last day of the most recent month for which the monthly financial statements and the related compliance certificate have been or are required to have been delivered to EBC, the Fixed Charge Coverage Ratio (as defined in the EBC Credit Agreement) for the 12 consecutive calendar month period then ended is greater than 1.10 to 1.00; and (ii) a capital expenditure limitation limiting the aggregate cost of all Capital Expenditure (as defined in the EBC Credit Agreement) to $2.5 million during any fiscal year. In addition, the EBC Credit Facilities contain customary affirmative and negative covenants.
We filed the EBC Credit Agreement as Exhibit 10.3 to our Quarterly Report on Form 10-Q for the quarter ended January 31, 2024 and the First Amendment as Exhibit 10.1 to our Quarterly Report on Form 10-Q for the quarter ended July 31, 2024.
Debt issuance costs related to the EBC Credit Agreement have been capitalized and the remaining balance, which is included as part of our other long-term assets balance, totaled $282,000 as of July 31, 2025.
As of July 31, 2025, our outstanding borrowings under the EBC Credit Agreement were $7,828,000. In accordance with ASC 470-10-45,Other Presentations Matters - General, we have classified the outstanding borrowings as part of current liabilities in the condensed consolidated balance sheet.
Note 13–** Cash dividend and declared dividends**
We didnot pay any dividends during the three or nine months ended July 31, 2025, nor during the three or nine months ended July 31, 2024.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.